U.S. pharma big copyright scrapped two experimental weight loss pills final year—a when-day by day pill, lotiglipron, resulting from elevated liver enzymes as well as a twice-each day tablet, danuglipron, due to powerful Unwanted side effects—but CEO Albert Bourla has mentioned the company is decided to “play and get” during the obesity Are